Combating Opioid-related Overdose

Similar documents
Understanding and Combating the Heroin Epidemic

Reducing opioid overdose mortality: role of communityadministered

Anyone Can Become Addicted. Anyone.

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

The Role of Urgent Care in responding to the opioid Crisis

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE

NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE

Opioid Use in Youth. Amy Yule M.D. March 2,

Naloxone (Narcan) Initiatives and the Court System

Opportunities for Opioid Safety and Community-Based Overdose Management

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition

Drug Class Review: Opioid Reversal Agents

Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation.

Take Home Naloxone: What Pharmacists Need to Know

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

MEDICATION ASSISTED TREATMENT

Opioids and Overdose 2017

Opioid education programs and nasal naloxone rescue kits

Prescription Opioids

Naloxone for Opioid Safety

NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE

Who is Behind the Opioid Epidemic?

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Prescribing Naloxone to Patients for Overdose Reversal

Take Home Naloxone Report on supply and use to reverse an overdose

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

Take Home Naloxone elearning Module Script

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

Welcome to the Opioid Overdose Prevention Project

Opiate Use Disorder and Opiate Overdose

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

Opioid Harm Reduction

Medication Assisted Treatment of Substance Use Disorders

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Advancing Addiction Science to Address the Opioid Crisis

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

8/12/2013. Drug overdose death rates in the US have more than tripled since 1990 (CDC 2011).

HARM REDUCTION & TREATMENT. Devin Reaves MSW

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

TELEPHONE SCREENING DEMOGRAPHIC INFO

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Pediatric Toxicology Update

Mobilizing a Response to the Opioid Epidemic: County Snapshots. Kelly Pfeifer, MD May 10, 2018

Vermont Hub and Spoke Model Treatment Need Questionnaire

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Naloxone Administration Training

2/21/2018. What are Opioids?

Aetna s Initiative on the Opioid Epidemic

How does polydrug use contribute to heroin overdose deaths? Risk to heroin users of concurrent use of pregabalin and gabapentin

Patient and Family Agreement on Opioids

What is the strategy?

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids

Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release

NALOXONE: HEALTHCARE PROFESSIONALS TRAINING GUIDE FOR ADMINISTRATION AND DISPENSING

Advancing Addiction Science to Address the Opioid Crisis

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

The Prescription Opioid and Heroin Crisis

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region

Responding to the Opioid Epidemic

Medication Assisted Treatment

Opioid Use Disorders &Medication Treatment

Strategies to Manage The Opioid Crisis

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Medical vs. Use of Drugs. Warning Signs of Chemical Dependence. Intent Effect. Legality Pattern 5/5/2010. Daily use above ceiling doses

Overdose Prevention: Empowering School Personnel & Families

Pregnancy, MAT and Addiction

Opioid Overdose Education and Naloxone Distribution

Earl Hightower's Remarks 2014 National Rx Drug Abuse Summit Medication Assisted Treatment for Opiate Addiction

Naloxone and Combating the Opioid Epidemic

Our Opioid Epidemic. The Opioid Mortality Crisis Continues 3/2/2017 STEPHEN R. BELL, DO

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER

Steve Alsum. The Grand Rapids Red Project. (616)

Changing Course: statewide efforts to combat the opioid epidemic in California

OVERDOSE PREVENTION AND EDUCATION OVERDOSE MANAGEMENT

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Rule Governing the Prescribing of Opioids for Pain

Buprenorphine as a Treatment Option for Opioid Use Disorder

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

New Guidelines for Prescribing Opioids for Chronic Pain

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Models of good practice in drug treatment in Europe. Project group

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Transcription:

Combating Opioid-related Overdose Kelly Dunn, Ph.D. Assistant Professor Behavioral Pharmacology Research Unit Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine

Presentation Outline Learn about the epidemiology of opioid overdose Understand what tools are available to help combat the opioid overdose epidemic 2

Treatment of Pain in the U.S. is a Billion Dollar Industry IMS Health, National Prescription Audit, Dec 2013

Narcotics are Among the Top 5 Prescribed Medications (2013) IMS Health, National Prescription Audit, Dec 2013 4

Overdose is Increasing Throughout the US MMWR, 2011. Vol. 60 (43) 5

Overdose is Increasing Throughout the US Between 2000-2014, rate of drug OD increased by 137% In 2014, 47,055 people died from drug OD, 61% involved opioids Drug poisoning is the leading cause of accidental death among adults aged 25-64. MMWR, 2011. Vol. 60 (43); MMWR, 2016. Vol. 64 (50), 1378-82 6

Fentanyl Exposure is Also Increasing DEA-DCT-DIB-021-16 DEA Intelligence Brief 7

Fentanyl Exposure is Also Increasing Beginning in 2013, the prevalence of fentanyl-adulterated heroin rose to unprecedented levels The rate of overdose related to fentanyl has increased 79% between 2013 and 2015 MMWR, 2016 8

Overdose is Increasing Throughout the US Opioid OD has increased in all segments of society: Drug users Chronic pain patients Elderly Children Women Adolescents Homeless Individuals Significant risk factors for OD Detoxification Leaving jail or prison Induction onto methadone treatment When used together with alcohol or benzodiazepines Baggett et al., 2013; Bailey et al., 2009; Bohnert et al., 2011; Cobaugh et al., 2006; Coben et al., 2010; Dunn et al., 2010; Palmiere et al., 2010; Paulozzi et al., 2006; Rosca et al., 2012

Presentation Outline Learn about the epidemiology of opioid overdose Understand what tools are available to help combat the opioid overdose epidemic 10

Naloxone The majority of published opioid OD interventions focus on naloxone (Narcan) Historically available via injection

Naloxone Auto-injector: Evzio (Kaleo Inc.) Approved by FDA on 4/3/2014

Approved by FDA on 11/18/2015 Narcan

IN vs. IV naloxone Time to Spontaneous Respiration (min) Time to Glascow Coma Score Kelly et al., 2005; Medical Journal of Australia

TM Exonal

Dunn et al., unpublished Naloxone Formulations

Dunn et al., unpublished Naloxone Formulations

Wheeler et al., 2015, MMWR Bystander Interventions

Efforts to Develop a Brief Screen The majority of opioid OD interventions focus on naloxone (Narcan) Non-naloxone approaches important because: Naloxone is not available everywhere Naloxone requires training to administer Price of naloxone has increased substantially Naloxone has many legal barriers Naloxone reverses OD but is not necessarily preventative Naloxone may not reverse OD that occurs with concurrent alcohol/benzodiazepine use

Brief Opioid Overdose Knowledge (BOOK) Questionnaire Identified 59 OD risk behaviors from literature, developed self-report measure Data collected in 3 phases Phase 1: Opioid users (N=147) recruited from detoxification settings Phase 2: Opioid users (N=199) recruited from MAT, detoxification, & needle exchange in VT and MD Phase 3: Patients currently prescribed opioids for the treatment of chronic pain (N=502), recruited via Amazon Mechanical Turk crowdsourcing Dunn et al., 2016, Journal of Addiction Medicine

Brief Opioid Overdose Knowledge (BOOK) Questionnaire Illicit Users Illicit Users Chronic Pain (Sample 1) (Sample 2) (Sample 3) (N=147) (N=199) (N=502) p-value a Aged over 30 (%) 36.9 23.2 32.5 0.02 Male (%) 67.1 46.5 44.9 <.001 Caucasian (%) 61.6 58.7 80.3 <.001 Never Married (%) 72.6 64.8 38.8 <.001 Employed (%) 36.1 27.1 85.5 <.001 Overdosed on opioids (%) 38.3 33.7 19.3 <.001 Witnessed an overdose (%) 70.9 64.0 38.0 <.001 Trained to administer naloxone (%) 7.2 33.9 7.2 <.001 a Values based on chi-square comparisons Symbols designate significant between-group differences. Shared symbols represent no siginificant difference between groups at p<.05 Dunn et al., 2016, Journal of Addiction Medicine 21

Brief Opioid Overdose Knowledge (BOOK) Questionnaire 12 True/False/I don t know items General knowledge (4 items) e.g. long vs short acting drugs, withdrawal signs Overdose risk knowledge (4 items) e.g. OD signs and symptoms; drug combos Overdose response knowledge (4 items) E.g. rescue breathing; Narcan Dunn et al., 2016, Journal of Addiction Medicine 22

Brief Opioid Overdose Knowledge (BOOK) Mean Correct Responses (range 0-4) 4 3 2 1 0 Performance on BOOK Subscales p<.001 Dunn et al., 2016, Journal of Addiction Medicine Questionnaire Illicit Users (Samples 1 & 2) Chronic Pain Patients (Sample 3) ns General Opioid Opioid OD Risk Knowledge Subscale p<.001 Opioid OD Response

OD in Chronic Pain Patients Surveyed 501 individuals who reported pain in past 3 months and treatment with opioid OD Experience 19.3% had experienced an OD 37.8% had witnessed an OD Only 3% had been trained to administer naloxone Past 30 day behaviors: 53.8% had used opioids alone 37.5% had combined opioids with alcohol Predominate RXOP users Dunn et al., 2016, Pain Medicine 24

OD in Chronic Pain Patients Evaluated numerous predictors of OD. Only 2 items emerged: SOAPP-R, DSM Checklist ROC analyses revealed that established cutoffs on two measures predicted history of OD: Screener and Opioid Assessment for Patients with Pain (SOAPP-R) >7 Mild Opioid Use Disorder (>2 items) Dunn et al., 2016, Pain Medicine

OD in Rural vs. Urban Settings Surveyed 345 individuals with opioid use disorder in rural (n=98) and urban (n=247) settings OD Experience 35.6% had experienced an OD 67.5% had witnessed an OD Only 16.9% had been trained to administer naloxone Past 30 day behaviors: 55.1% had used opioids alone 45.6% had combined opioids with alcohol Predominate heroin users 26 Dunn et al., in press, Pain Medicine

OD in Rural vs. Urban Settings Table 2. Overdose History and Risk Factors Entire Sample Participants with History of Overdose Total Rural Urban p-value Total OD Rural OD Urban OD p-value (N=345) (N=98) (N=247) (N=123) (N=45) (N=78) Overdose (OD) History Lifetime Overdose (%) 35.6 45.9 31.6 <.01 100 100 100 N/A Number ODs (mean times, SD) a 1.3 (2.2) 1.5 (2.5) 1.0 (2.0) 0.04 3.2 (2.6) 3.3 (2.8) 3.1 (2.4) 0.66 OD past 30 days (%) 15.4 10.1 18.2 0.28 15.6 10.1 18.5 0.23 OD past year (%) 46.1 47.4 45.5 0.51 46.1 45.9 46.2 0.57 Gone to Emergency Department for OD (%) 26.1 31.9 23.9 0.08 45.1 34.1 51.3 0.05 Witnessed OD (%) 67.5 74.4 64.9 0.07 73.0 69.2 75.0 0.33 Naloxone History Received naloxone prescription (%) 16.9 34.4 9.6 <.001 20.5 39.5 9.5 <.001 Trained to administer naloxone (%) 22.6 46.9 12.6 <.001 22.9 48.8 8.0 <.001 Trained to administer CPR (%) 49.2 59.4 45.0 0.01 46.6 62.7 37.3 <.01 Past 30 Day Risk Behaviors (%) Used opioids by themselves 55.1 41.9 60.3 0.001 60.1 37.8 74.4 <.001 Number days past 30 (mean days, SD) a 2.0 (2.3) 1.2 (1.9) 2.7 (2.6) <.001 2.1 (2.0) 1.0 (1.6) 3.2 (2.5) <.001 Combining opioids with alcohol 45.6 32.6 50.1 <.01 61.2 38.9 64.1 <.001 Number days past 30 (mean days, SD) a 1.5 (2.0) 0.7 (1.5) 2.2 (2.6) <.001 1.5 (1.9) 0.5 (1.2) 2.5 (2.5) <.001 Using methadone 17.1 6.1 21.5 <.001 16.3 4.4 23.1 <.01 Number days past 30 (mean days, SD) a 0.3 (.93) 0.1 (.53) 0.5 (1.4) <.01 0.3 (.85) 0.1 (.47) 0.5 (1.2) 0.06 Undergoing detoxification from opioids 48.5 10.2 64.3 <.001 49.6 6.7 75.0 <.001 Number days past 30 (mean days, SD) a 0.5 (.99) 0.2 (.71) 0.9 (1.27) <.001 0.5 (.76) 0.1 (.25) 0.9 (1.3) <.001 Been in jail or prison 7.2 7.1 7.3 0.58 6.5 8.9 5.1 0.32 Number days past 30 (mean days, SD) a 0.2 (.07) 0.1 (.45) 0.2 (.91) 0.29 0.1 (.39) 0.2 (.56) 0.1 (.22) 0.15 P-values based on Chi-squares for dichotomous variables and independent groups t-tests for continuous variables. OD=overdose; SD=standard deviation a Represents mean reported by participants who endorsed the event b Defined as stimulants and/or benzodiazepines Dunn et al., 2016, 27 JSAT

OD in Rural vs. Urban 1 Settings Mean (SEM) C Only predictor of OD was performance on the BOOK Opioid and Knowledge Domain Opioid OD Knowledge subscales 0 General Opioid Opioid OD Risk Opioid OD Response Mean (SEM) Correct Responses 3 2 1 All 2D Participants Graph 2 4 Rural (N=98) Urban (N=247) Mean (SEM) Correct Responses 4 3 2 1 2D Graph 2 Participants with a History of OD * * Rural (N=45) Urban (N=78) * 0 General Opioid Opioid OD Risk Opioid OD Response Knowledge Domain 0 General Opioid Opioid OD Risk Opioid OD Response Knowledge Domain 2D Graph 2 Dunn et al., 2016, 28 JSAT

Opioid OD Knowledge Intervention Educational interventions Strengths: Show immediate and sustained gains in knowledge Limitations: Not yet evaluated in RCT Generally targeted towards drug users Often administered by trained professional in individualized or group settings Majority of published interventions focus primarily on naloxone administration Green et al., 2008; Piper et al., 2007; Strang et al., 2008; Tobin et al., 2009; Wagner et al., 2010

Opioid OD Knowledge Intervention RCT of an educational intervention Randomized to 1 of 3 groups: Pamphlets Computer intervention Computer intervention with questions Complete pre and post knowledge test; Single administration of intervention Complete 1 and 3 month follow-ups to assess extended knowledge

Opioid OD Knowledge Intervention

Opioid OD Knowledge Intervention

Opioid OD Knowledge Intervention

Opioid OD Knowledge Intervention Opioid users (N=76) recruited from 3-5 day outpatient buprenorphine detoxification program OD Experience 36.0% had experienced an OD 53.6% had witnessed an OD Only 10.6% had been trained to administer naloxone Past 30 day behaviors: 56.0% had used opioids alone 91.2% had combined opioids with alcohol Predominate heroin users 34 Dunn et al., under review

Opioid OD Knowledge Intervention 100 Opioid Knowledge Opioid OD Knowledge Opioid OD Response Knowledge 80 Mean Percent 60 40 20 0 Pre Pamphlet Computer Computer + Mastery Timepoint Post Pre Timepoint Post Pre Timepoint Post Dunn et al., under review

Opioid OD Knowledge Intervention The majority (87%) of participants had relapsed to opioids 9.4% had witnessed an OD by the 30-day follow-up Significant reductions in number of days used opioids alone in past 30, and combining opioids and alcohol 36 Dunn et al., under review

Opioid OD Knowledge Intervention 100 Opioid Knowledge Opioid OD Knowledge Opioid OD Response Knowledge Mean Percent Correct 80 60 40 20 0 Pamphlet Computer Computer + Mastery Pre. Post 1 m 3 m Timepoint Pre. Post 1 m 3 m Timepoint Pre. Post 1 m 3 m Timepoint Dunn et al., under review

Opioid OD Knowledge Intervention The Educational Intervention: a Pamphlet Computer Computer + Mastery (N=25) (N=24) (N=27) Was helpful 1.6 (0.9) 1.4 (0.9) 1.6 (0.9) 0.73 Taught me information I did not know before 1.6 (0.7) 1.5 (0.9) 1.5 (0.9) 0.21 Was easy to understand 1.9 (0.9) 1.3 (0.5) 1.5 (0.5) 0.03 Was fun 2.6 (1.2) 2.3 (0.9) 2.2 (1.1) 0.42 Took too long 2.7 (1.3) 3.3 (1.0) 3.2 (1.4) 0.14 Was Interesting 2.2 (1.2) 1.8 (1.0) 1.7 (0.7) 0.33 I would recommend this educational intervention to someone else a 2.2 (1.1) 1.5 (1.0) 1.7 (0.9) 0.20 I believe that more people should receive this educational intervention a 1.8 (1.2) 1.4 (1.0) 1.6 (1.0) 0.43 I DO NOT think that the educational intervention was useful a 4.0 (1.3) 4.2 (1.0) 4.3 (0.9) 0.47 The educational intervention was confusing a 3.7 (1.3) 4.2 (1.0) 3.9 (1.1) 0.05 How important is it to learn to prevent, recognize, and respond to an overdose b 2.0 (0) 2.0 (0) 2.0 (0.2) 0.39 This intervention will help me from overdosing in the future (%) 96.0 100.0 100.0 0.02 Feel this intervention will change the way you help people who are overdosing (%) 96.0 95.8 100 0.58 Would recommend this intervention to a family member or friend (%) 100 100 100 a Rated on 5-point Likert Scale: 1=Strongly Agree, 2=Agree, 3=Neither Agree not Disagree, 4=Disagree, 5=Strongly Disagree b Rated on 3-point Likert Scale: 0=Not at all Important, 1=Somewhat Important, 2=Very Important p-value Dunn et al., under review

Conclusions Opioid OD is a serious public health problem Brief Opioid Overdose Knowledge (BOOK) may have value as an outcome measure and clinically to inform conversations with patients Risk behaviors and low knowledge are prevalent across multiple different populations Computer-based intervention produces sustained gains in knowledge

Acknowledgements Many thanks to the Johns Hopkins Chemical Dependency Unit, Kathy Petrush, Suzan Berman, Anne Kelly, Carl Broker, and Eric Cunningham NIDA: R21 DA035327; R01DA035246 Thank you! Contact me at: Kelly Dunn, Ph.D. kdunn9@jhmi.edu P: 410-550-2254 40

Dunn et al., under review 41